CIK 0001818844 · Non-accelerated filer<br>Smaller reporting company
Dogwood Therapeutics, Inc.
Sign in to watch- Ticker
- DWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 854314201
- Phone
- 8666208655
- Business address
- 44 MILTON AVENUE, ALPHARETTA, GA, 30009
- Former names
- Virios Therapeutics, Inc., Virios Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-27 | Thomas John C Director | Grant or award · Stock Option (right to buy) | +2,362 | 2,362 | ||
| 2025-06-27 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2025-06-27 | Keefer David R Director | Grant or award · Stock Option (right to buy) | +2,362 | 2,362 | ||
| 2025-06-27 | Walsh Angela Chief Financial Officer | Grant or award · Stock Option (right to buy) | +12,075 | 12,075 | ||
| 2025-06-27 | De La Rosa Abel Director | Grant or award · Stock Option (right to buy) | +2,362 | 2,362 | ||
| 2025-06-18 | Whitley Richard James Director | Grant or award · Stock Option (right to buy) | +210 | 210 | ||
| 2025-06-18 | Whitley Richard James Director | Grant or award · Stock Option (right to buy) | +210 | 420 | ||
| 2025-06-18 | Keefer David R Director | Grant or award · Stock Option (right to buy) | +210 | 210 | ||
| 2025-06-18 | Keefer David R Director | Grant or award · Stock Option (right to buy) | +210 | 420 | ||
| 2025-06-18 | Thomas John C Director | Grant or award · Stock Option (right to buy) | +210 | 210 | ||
| 2025-06-18 | Thomas John C Director | Grant or award · Stock Option (right to buy) | +210 | 420 | ||
| 2025-06-18 | De La Rosa Abel Director | Grant or award · Stock Option (right to buy) | +210 | 210 | ||
| 2025-06-18 | De La Rosa Abel Director | Grant or award · Stock Option (right to buy) | +210 | 420 | ||
| 2025-03-12 | CK Life Sciences Intl (Holdings) Inc Director | Grant or award · Series A-1 Preferred Stock | +284.26 | $7.01 | $2K | 284.26 |
| 2024-02-26 | Pridgen William Director | Grant or award · Stock Option (right to buy) | +2,917 | 2,917 | ||
| 2024-02-26 | Thomas John C Director | Grant or award · Stock Option (right to buy) | +4,167 | 4,167 | ||
| 2024-02-26 | Whitley Richard James Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2024-02-26 | Keefer David R Director | Grant or award · Stock Option (right to buy) | +4,709 | 4,709 | ||
| 2024-02-26 | Burch Richard Alan Director | Grant or award · Stock Option (right to buy) | +2,917 | 2,917 | ||
| 2024-02-26 | De La Rosa Abel Director | Grant or award · Stock Option (right to buy) | +3,959 | 3,959 |
Page 2 of 6 · 113 trades